Search Results - "Terwel, Sofie"
-
1
Calcium homeostasis and low-frequency magnetic and electric field exposure: A systematic review and meta-analysis of in vitro studies
Published in Environment international (01-07-2016)“…Low frequency magnetic field (LF MF) exposure is recurrently suggested to have the ability to induce health effects in society. Therefore, in vitro model…”
Get full text
Journal Article -
2
Daily home fortification with iron as ferrous fumarate versus NaFeEDTA: a randomised, placebo-controlled, non-inferiority trial in Kenyan children
Published in BMC medicine (28-04-2017)“…We aimed to show the non-inferiority of home fortification with a daily dose of 3 mg iron in the form of iron as ferric sodium ethylenediaminetetraacetate…”
Get full text
Journal Article -
3
Late diagnosis of HIV infection in asymptomatic patients
Published in Medicina (Buenos Aires) (01-01-2016)“…Recent findings from the START Trial provided evidence that early initiation of antiretroviral treatment should be implemented as the global standard of care…”
Get full text
Journal Article -
4
Comparison of home fortification with two iron formulations among Kenyan children: Rationale and design of a placebo-controlled non-inferiority trial
Published in Contemporary clinical trials communications (01-09-2017)“…Abstract Introduction Home fortification powders containing iron and other micronutrients have been recommended by World Health Organisation to prevent iron…”
Get full text
Journal Article -
5
Opportunities and challenges associated with the evaluation of chimeric antigen receptor T cells in real-life
Published in Current opinion in oncology (01-09-2020)“…PURPOSE OF REVIEWWith the approval of the first chimeric antigen receptor (CAR)-T cell products on the market, the European Medicines Agency (EMA) required…”
Get full text
Journal Article -
6
Implementation and operational management of marketed chimeric antigen receptor T cell (CAR-T Cell) therapy—a guidance by the GoCART Coalition Pharmacist Working Group
Published in Bone marrow transplantation (Basingstoke) (01-10-2023)“…Chimeric Antigen Receptor T cells (CAR-T cells) are a type of Advanced Therapy Medicinal Product (ATMP) classified as ex-vivo (cell-based) gene therapy. CAR-T…”
Get full text
Journal Article -
7
Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWP
Published in Bone marrow transplantation (Basingstoke) (01-09-2018)Get full text
Journal Article -
8
CAR-T CELLS: How does the EBMT registry monitor European activities, identify hurdles and prepare for changes in regulations
Published in Bulletin du cancer (01-10-2021)“…CAR-T Cells are gene therapy medicinal products, a subcategory of Advanced Therapy Medicinal Products as defined in the EC Regulation 1394/2007. They may…”
Get full text
Journal Article -
9
How to Monitor Immune Reconstitution Following Allogeneic Hematopoietic Stem Cell Transplantation: A Survey from the EBMT- Cellular Therapy & Immunobiology Working Party
Published in Blood (02-12-2016)“…Background: Post transplant immune reconstitution plays a major role in determining the outcome of allogeneic hematopoietic stem cell transplantation…”
Get full text
Journal Article -
10
CAR-T cells : comment le registre de l’EBMT monitore les activités en Europe, identifie les contraintes et prépare l’évolution des régulations
Published in Bulletin du cancer (01-10-2021)“…Les CAR-T cells sont des médicaments de thérapie génique, une sous-catégorie des médicaments de thérapie innovante définis par le Règlement européen 2007/1394…”
Get full text
Journal Article